{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:10:23Z","timestamp":1787242223496,"version":"build-2736575974"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"vor","delay-in-days":52,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"DOI":"10.1038\/s41398-025-03751-3","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T09:14:04Z","timestamp":1764062044000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Comparative gastrointestinal effects of antidepressants for the acute treatment of adults with major depressive disorder: a network and dose\u2012response meta-analysis"],"prefix":"10.1038","volume":"16","author":[{"given":"Sixiang","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushun","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junru","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6210-3206","authenticated-orcid":false,"given":"Yikai","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2627-9946","authenticated-orcid":false,"given":"Xiaohong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"key":"3751_CR1","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","volume":"392","author":"GBD Chronic Kidney Disease Collaboration.","year":"2018","unstructured":"GBD Chronic Kidney Disease Collaboration. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1789\u2013858.","journal-title":"Lancet"},{"key":"3751_CR2","unstructured":"World Health Organization. Regional Office for the Eastern M. Depression. Cairo: World Health Organization. Regional Office for the Eastern Mediterranean; 2019 2019-11. Contract No.: WHO-EM\/MNH\/219\/E."},{"key":"3751_CR3","doi-asserted-by":"crossref","unstructured":"Patel V, Chisholm D, Parikh R, Charlson FJ, Whiteford H Addressing the burden of mental, neurological, and substance use disorders: key messages from Disease Control Priorities, 3rd edition. Lancet. 2016.","DOI":"10.4103\/0971-9962.193189"},{"key":"3751_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.988648","volume":"13","author":"K Stachowicz","year":"2022","unstructured":"Stachowicz K, Sowa-Ku\u0107ma M. The treatment of depression - searching for new ideas. Front Pharm. 2022;13:988648.","journal-title":"Front Pharm"},{"key":"3751_CR5","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.jad.2009.06.043","volume":"117","author":"SH Kennedy","year":"2009","unstructured":"Kennedy SH, Lam RW, Parikh SV, Patten SB, Ravindran AV. Canadian network for mood and anxiety treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. Introduction J Affect Disord. 2009;117:S1\u20132.","journal-title":"Introduction J Affect Disord"},{"key":"3751_CR6","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0140-6736(22)02080-3","volume":"401","author":"S Marwaha","year":"2023","unstructured":"Marwaha S, Palmer E, Suppes T, Cons E, Young AH, Upthegrove R. Novel and emerging treatments for major depression. Lancet. 2023;401:141\u201353.","journal-title":"Lancet"},{"key":"3751_CR7","doi-asserted-by":"publisher","first-page":"Itc65","DOI":"10.7326\/AITC202105180","volume":"174","author":"RM McCarron","year":"2021","unstructured":"McCarron RM, Shapiro B, Rawles J, Luo J. Depression. Ann Intern Med. 2021;174:Itc65\u2013itc80.","journal-title":"Ann Intern Med"},{"key":"3751_CR8","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1177\/0706743716659417","volume":"61","author":"SH Kennedy","year":"2016","unstructured":"Kennedy SH, Lam RW, McIntyre RS, Tourjman SV, Bhat V, Blier P, et al. Canadian network for mood and anxiety treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder:section 3. pharmacological treatments. Canadian J Psychiatry. 2016;61:540\u201360.","journal-title":"Canadian J Psychiatry"},{"key":"3751_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2019.109755","volume":"96","author":"Y Zhu","year":"2020","unstructured":"Zhu Y, Wu Z, Sie O, Cai Y, Huang J, Liu H, et al. Causes of drug discontinuation in patients with major depressive disorder in China. Prog Neuropsychopharmacol Biol Psychiatry. 2020;96:109755.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"3751_CR10","doi-asserted-by":"publisher","first-page":"239","DOI":"10.7326\/M22-2056","volume":"176","author":"E Wood","year":"2023","unstructured":"Wood E, Rehm J. Nonpharmacologic and pharmacologic treatments of adults in the acute phase of major depressive disorder: a living clinical guideline from the american college of physicians. Ann Intern Med. 2023;176:239\u201352.","journal-title":"Ann Intern Med"},{"key":"3751_CR11","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1159\/000447034","volume":"85","author":"AF Carvalho","year":"2016","unstructured":"Carvalho AF, Sharma MS, Brunoni AR, Vieta E, Fava GA. The safety, tolerability and risks associated with the use of newer generation antidepressant drugs: a critical review of the literature. Psychother Psychosom. 2016;85:270\u201388.","journal-title":"Psychother Psychosom"},{"key":"3751_CR12","first-page":"173","volume":"107","author":"H Kovich","year":"2023","unstructured":"Kovich H, Kim W, Quaste AM. Pharmacologic treatment of depression. Am Fam Physician. 2023;107:173\u201381.","journal-title":"Am Fam Physician"},{"key":"3751_CR13","first-page":"1245","volume":"159","author":"E Trindade","year":"1998","unstructured":"Trindade E, Menon D, Topfer LA, Coloma C. Adverse effects associated with selective serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis. CMAJ. 1998;159:1245\u201352.","journal-title":"CMAJ"},{"key":"3751_CR14","volume-title":"Drug Class Reviews. Drug Class Review: Second-Generation Antidepressants: Final Update 5 Report.","author":"G Gartlehner","year":"2011","unstructured":"Gartlehner G, Hansen RA, Reichenpfader U, Kaminski A, Kien C, Strobelberger M et al. Drug Class Reviews. Drug Class Review: Second-Generation Antidepressants: Final Update 5 Report. Portland (OR): Oregon Health & Science University Copyright \u00a9 2011 Oregon Health & Science University; 2011."},{"key":"3751_CR15","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1038\/s41380-018-0093-6","volume":"25","author":"WK Simmons","year":"2020","unstructured":"Simmons WK, Burrows K, Avery JA, Kerr KL, Taylor A, Bodurka J, et al. Appetite changes reveal depression subgroups with distinct endocrine, metabolic, and immune states. Mol Psychiatry. 2020;25:1457\u201368.","journal-title":"Mol Psychiatry"},{"key":"3751_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2021.110266","volume":"109","author":"V Oliva","year":"2021","unstructured":"Oliva V, Lippi M, Paci R, Del Fabro L, Delvecchio G, Brambilla P, et al. Gastrointestinal side effects associated with antidepressant treatments in patients with major depressive disorder: A systematic review and meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry. 2021;109:110266.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"3751_CR17","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/S2215-0366(19)30217-2","volume":"6","author":"TA Furukawa","year":"2019","unstructured":"Furukawa TA, Cipriani A, Cowen PJ, Leucht S, Egger M, Salanti G. Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: a systematic review and dose-response meta-analysis. Lancet Psychiatry. 2019;6:601\u20139.","journal-title":"Lancet Psychiatry"},{"key":"3751_CR18","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1192\/bjp.bp.108.061960","volume":"195","author":"R Uher","year":"2009","unstructured":"Uher R, Farmer A, Henigsberg N, Rietschel M, Mors O, Maier W, et al. Adverse reactions to antidepressants. Br J Psychiatry. 2009;195:202\u201310.","journal-title":"Br J Psychiatry"},{"key":"3751_CR19","doi-asserted-by":"crossref","unstructured":"Higgins JP, Green S Cochrane Handbook for Systematic Reviews of Interventions. Wiley-Blackwell. 2008.","DOI":"10.1002\/9780470712184"},{"key":"3751_CR20","doi-asserted-by":"publisher","first-page":"e010919","DOI":"10.1136\/bmjopen-2015-010919","volume":"6","author":"TA Furukawa","year":"2016","unstructured":"Furukawa TA, Salanti G, Atkinson LZ, Leucht S, Ruhe HG, Turner EH, et al. Comparative efficacy and acceptability of first-generation and second-generation antidepressants in the acute treatment of major depression: protocol for a network meta-analysis. BMJ Open. 2016;6:e010919.","journal-title":"BMJ Open"},{"key":"3751_CR21","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","volume":"64","author":"G Salanti","year":"2011","unstructured":"Salanti G, Ades AE, Ioannidis JP. Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial. J Clin Epidemiol. 2011;64:163\u201371.","journal-title":"J Clin Epidemiol"},{"key":"3751_CR22","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1002\/sim.3767","volume":"29","author":"S Dias","year":"2010","unstructured":"Dias S, Welton NJ, Caldwell DM, Ades AE. Checking consistency in mixed treatment comparison meta-analysis. Stat Med. 2010;29:932\u201344.","journal-title":"Stat Med"},{"key":"3751_CR23","doi-asserted-by":"publisher","first-page":"e99682","DOI":"10.1371\/journal.pone.0099682","volume":"9","author":"G Salanti","year":"2014","unstructured":"Salanti G, Del Giovane C, Chaimani A, Caldwell DM, Higgins JP. Evaluating the quality of evidence from a network meta-analysis. PLoS ONE. 2014;9:e99682.","journal-title":"PLoS ONE"},{"key":"3751_CR24","doi-asserted-by":"publisher","first-page":"g5630","DOI":"10.1136\/bmj.g5630","volume":"349","author":"MA Puhan","year":"2014","unstructured":"Puhan MA, Sch\u00fcnemann HJ, Murad MH, Li T, Brignardello-Petersen R, Singh JA, et al. A GRADE working group approach for rating the quality of treatment effect estimates from network meta-analysis. BMJ. 2014;349:g5630.","journal-title":"BMJ"},{"key":"3751_CR25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S2215-0366(24)00006-3","volume":"11","author":"V Oliva","year":"2024","unstructured":"Oliva V, Possidente C, Prisco MD, Fico G, Anmella G, Hidalgo-Mazzei D, et al. Pharmacological treatments for psychotic depression: a systematic review and network meta-analysis. Lancet Psychiatry. 2024;11:11.","journal-title":"Lancet Psychiatry"},{"key":"3751_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-016-0189-0","volume":"16","author":"A Crippa","year":"2016","unstructured":"Crippa A, Orsini N. Dose-response meta-analysis of differences in means. BMC Med Res Methodol. 2016;16:91.","journal-title":"BMC Med Res Methodol"},{"key":"3751_CR27","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557\u201360.","journal-title":"BMJ"},{"key":"3751_CR28","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1097\/MCG.0000000000001164","volume":"53","author":"DJ Cangemi","year":"2019","unstructured":"Cangemi DJ, Kuo B. Practical perspectives in the treatment of nausea and vomiting. J Clin Gastroenterol. 2019;53:170\u20138.","journal-title":"J Clin Gastroenterol"},{"key":"3751_CR29","unstructured":"Moraczewski J, Awosika AO, Aedma KK Tricyclic Antidepressants. StatPearls. Treasure Island (FL) ineligible companies. Disclosure: Ayoola Awosika declares no relevant financial relationships with ineligible companies. Disclosure: Kapil Aedma declares no relevant financial relationships with ineligible companies: StatPearls Publishing Copyright \u00a9 2024, StatPearls Publishing LLC.; 2024."},{"key":"3751_CR30","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1053\/j.gastro.2015.04.020","volume":"149","author":"NJ Talley","year":"2015","unstructured":"Talley NJ, Locke GR, Saito YA, Almazar AE, Bouras EP, Howden CW, et al. Effect of amitriptyline and escitalopram on functional dyspepsia: a multicenter, randomized controlled study. Gastroenterology. 2015;149:340\u20139.e2.","journal-title":"Gastroenterology"},{"key":"3751_CR31","doi-asserted-by":"crossref","unstructured":"Shanmugham S, Zuber M, Chan JE, Kumar S, Ching SM, Lee YY, et al. Efficacy of antidepressants in functional dyspepsia: Systematic review and meta-analysis with trial sequential analysis of randomized controlled trials. Indian J Gastroenterol. 2025;44:24\u201334.","DOI":"10.1007\/s12664-024-01648-5"},{"key":"3751_CR32","unstructured":"Jilani TN, Gibbons JR, Faizy RM, Saadabadi A Mirtazapine. StatPearls. Treasure Island (FL) ineligible companies. Disclosure: Jonathan Gibbons declares no relevant financial relationships with ineligible companies. Disclosure: Rubina Faizy declares no relevant financial relationships with ineligible companies. Disclosure: Abdolreza Saadabadi declares no relevant financial relationships with ineligible companies.: StatPearls Publishing Copyright \u00a9 2025, StatPearls Publishing LLC.; 2025."},{"key":"3751_CR33","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1002\/oby.22969","volume":"28","author":"H Gill","year":"2020","unstructured":"Gill H, Gill B, El-Halabi S, Chen-Li D, Lipsitz O, Rosenblat JD, et al. Antidepressant medications and weight change: a narrative review. Obesity (Silver Spring). 2020;28:2064\u201372.","journal-title":"Obesity (Silver Spring)"},{"key":"3751_CR34","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1016\/j.jaip.2024.08.030","volume":"12","author":"M Kosinski","year":"2024","unstructured":"Kosinski M, Nelson LM, Stanford RH, Flom JD, Schatz M. Patient-reported outcome measure development and validation: a primer for clinicians. J Allergy Clin Immunol Pr. 2024;12:2554\u201361.","journal-title":"J Allergy Clin Immunol Pr"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-025-03751-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-025-03751-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-025-03751-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T08:16:59Z","timestamp":1768551419000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-025-03751-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3751"],"URL":"https:\/\/doi.org\/10.1038\/s41398-025-03751-3","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"assertion":[{"value":"7 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"34"}}